Search Results
-
FILTER BY DATEAll Time
-
-
FILTER BY RELEVANCEMost Relevant
-
-
FILTER BY CONTENT TYPEAll Content Types
-
Authorities should focus on India's real health problem: fake and substandard medicines.
American Enterprise Institute (AEI) scholar Scott Gottlieb, MD a former senior adviser to the Center for Medicare and Medicaid Services (CMS) warns that a new ruling by CMS will force people to get open-heart surgeries that might have been avoidable.
AEI's annual compilation of polling data on the environment, key issues and findings
Gov. Bob McDonnell (R-Va.) has long been on almost everyone's short list for the Republican vice presidential nomination. But now McDonnell's national security credentials have come into question, thanks to his mishandling of a bill passed by the Virginia General Assembly.
"Off-label" prescribing--that is, doctors prescribing drugs for purposes other than those expressly approved by the Food and Drug Administration (FDA--is often useful although little is known of its extent. In the last several years, nearly every major pharmaceutical company has paid hundreds of millions of dollars to settle allegations of...
The World Health Organizationhas just endorsed medicines that havenotpassed muster with western regulators.
Post-approval drug safety surveillance is an extraordinarily difficult task.The Vioxx episode has probably made it more difficult for the Food and Drug Administration to do its job.
Washington Post editorial writer and liberal blogger Jonathan Capehart is puzzled. Why does the "non-issue" of Harvard law professor and Democratic Senate candidate Elizabeth Warren's Native American ancestry "require so much attention?" he asked last week.
When Warren was teaching at Pennsylvania, Texas and...





